When Should Statins Be Stopped?

Eur J Case Rep Intern Med. 2021 Jun 15;8(7):002661. doi: 10.12890/2021_002661. eCollection 2021.

Abstract

Mycobacterium chelonae is a non-tuberculous mycobacterium that can cause skin infections in immunocompetent individuals. We report a case of skin infection by this agent in a woman with dyslipidaemia, that culminated in statin-induced rhabdomyolysis due to the combination of clarithromycin, ciprofloxacin and simvastatin.

Learning points: Skin infection with Mycobacterium chelonae is an increasing global problem among immunocompetent individuals.Statin-induced rhabdomyolysis is an important and avoidable end-result of drug-drug interaction.Inhibition of cytochrome P450 isoenzyme 3A4 and of organic anion transporting polypeptide 1B1 are two important examples of statin interference with metabolism, and clarithromycin can inhibit both.

Keywords: Mycobacterium chelonae; ciprofloxacin; clarithromycin; statin-induced rhabdomyolysis.